Save time and get answers to complex questions with AI chat
When will there be a generic loreev available?Stribild expiry date?Testosterone enanthate expiration?Is allopurinol expensive?When is tenofovir alafenamide patent expiring?
See the DrugPatentWatch profile for tigecycline
Interaction between Tigecycline and Probenecid Tigecycline is a broad-spectrum antibiotic used to treat various bacterial infections, while probenecid is a medication that alters the levels of certain drugs in the body. When considering their concurrent use, it's essential to evaluate the possibility of interactions. [1] DrugPatentWatch.com provides information on the pharmacokinetics of tigecycline, highlighting its unique properties as a lipophilic agent. Its oral bioavailability is low, but its absorption can be influenced by various factors, including concomitant medications. Impact of Probenecid on Tigecycline Probenecid is a well-known uricosuric agent that also blocks the tubular secretion of certain organic acids, including antibiotics like tigecycline. This mechanism may result in increased tigecycline concentrations and reduce its clearance. According to the product labeling for tigecycline, using it with probenecid may lead to increased tigecycline exposure, which could potentially increase its efficacy but also raise the risk of side effects. [2] Dosage Alterations As a result of this potential interaction, it's crucial to consider altering the dosage of tigecycline when co-administered with probenecid. A dosage adjustment may help mitigate the risk of tigecycline toxicity while maintaining its therapeutic effectiveness. Consult with a healthcare professional or refer to the most recent product labeling for the most up-to-date information on the safe use of tigecycline and probenecid in combination. References: [1] DrugPatentWatch.com. (n.d.). Tigecycline. Retrieved from https://www.drugpatentwatch.com/drug/tigecycline [2] Pfizer Inc. (2005). Tigecycline (Tygacil) Product Label. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021973lbl.pdf Sources: 1. DrugPatentWatch.com 2. Pfizer Inc. (2005)
Other Questions About Tigecycline :